CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on creating innovative light-activated ligands that can reversibly bind to ribonucleic acid (RNA). This technology has potential applications in cancer, antiviral, and antimicrobial therapies by controlling RNA function.
The proposed project aims at the development of novel functional ligands whose association with ribonucleic acid (RNA) is reversibly activated by light.
As several RNA forms are essential key elements in physiological processes, the control of their function or malfunction by the reversible binding of photoswitchable ligands possesses a great potential as a tool in anticancer, antiviral and antimicrobial therapy.
Surprisingly, this innovative approach towards a controlled reversible generation…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
